APRILBIO CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14,510 KRW | -0.55% |
|
-6.57% | -13.89% |
| Sales 2023 | - | Sales 2024 * | 22.5B 16.54M | Capitalization | 315B 232M |
|---|---|---|---|---|---|
| Net income 2023 | -14B -10.29M | Net income 2024 * | -10B -7.35M | EV / Sales 2023 | - |
| Net cash position 2023 | 41.63B 30.6M | Net cash position 2024 * | 82B 60.27M | EV / Sales 2024 * | 10.4 x |
| P/E ratio 2023 |
-21.9
x | P/E ratio 2024 * |
-31.9
x | Employees | - |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 69.59% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.55% | ||
| 1 week | -6.57% | ||
| Current month | -3.46% | ||
| 1 month | -3.46% | ||
| 3 months | +4.84% | ||
| 6 months | +25.95% | ||
| Current year | -13.89% |
1 week
14 100.00
15 330.00
1 month
14 100.0016 920.00
Current year
11 510.0019 150.00
1 year
9 115.0019 150.00
3 years
5 200.0019 150.00
5 years
5 200.0019 150.00
10 years
5 200.0019 150.00
| Managers | Title | Age | Since |
|---|---|---|---|
Sang-Hun Cha
FOU | Founder | 61 | 13-02-11 |
Jin-Taek Kim
DFI | Director of Finance/CFO | 53 | - |
Moo-Young Song
CTO | Chief Tech/Sci/R&D Officer | 57 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sang-Hun Cha
FOU | Founder | 61 | 13-02-11 |
Jin-Taek Kim
DFI | Director of Finance/CFO | 53 | - |
Eun-Jik Lee
BRD | Director/Board Member | 65 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-24 | 14,510 | -0.55% | 161,562 |
| 24-05-23 | 14,590 | -1.88% | 130,289 |
| 24-05-22 | 14,870 | -1.72% | 143,682 |
| 24-05-21 | 15,130 | +0.73% | 80,899 |
| 24-05-20 | 15,020 | -3.28% | 129,330 |
End-of-day quote Korea S.E., May 23, 2024
More quotes
AprilBio Co Ltd is a Korea-based company primarily engaged in the biological drug development business. The Company is primarily engaged in the bio-innovative new drug research and development (R&D) business such as antibody therapeutics and long-acting recombinant protein pharmaceuticals.
Calendar
2024-08-11
- Q2 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
14,510
KRW
Average target price
27,000
KRW
Spread / Average Target
+86.08%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -13.89% | 231M | |
| +12.30% | 118B | |
| +12.15% | 106B | |
| -8.14% | 23.4B | |
| -1.28% | 21.78B | |
| -9.10% | 18.09B | |
| -41.25% | 16.72B | |
| -15.33% | 15.97B | |
| +5.80% | 14.03B | |
| +28.03% | 11.67B |
- Stock Market
- Equities
- A397030 Stock
